Tekmira Achieves $1.5 Million Development Milestone
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Needham Starts NeoVolta (NEOV) at Buy
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Rockstar Games opens GTA VI pre-orders, priced at $79.99
- Rubio meets Gulf leaders, pledges security amid Iran deal doubts
Tekmira Pharmaceuticals (TKMR) Reaches $1.5M Milestone in Monsanto (MON) Agreement
October 3, 2014 6:22 AM EDTTekmira Pharmaceuticals (Nasdaq: TKMR) announced that it has achieved a development milestone supporting a $1.5 million payment from Monsanto (NYSE: MON), following completion of specified program objectives. This work is part of the research program under the Option Agreement Tekmira signed... More
